A computational analysis of pro-angiogenic therapies for peripheral artery disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A computational analysis of pro-angiogenic therapies for peripheral artery disease
Authors
Keywords
-
Journal
Integrative Biology
Volume 10, Issue 1, Pages 18-33
Publisher
Royal Society of Chemistry (RSC)
Online
2018-01-04
DOI
10.1039/c7ib00218a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands
- (2017) Lindsay E. Clegg et al. PLoS Computational Biology
- VEGF 165 b Modulates Endothelial VEGFR1–STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial DiseaseNovelty and Significance
- (2016) Vijay Chaitanya Ganta et al. CIRCULATION RESEARCH
- VEGFR-2 conformational switch in response to ligand binding
- (2016) Sarvenaz Sarabipour et al. eLife
- Design principles for therapeutic angiogenic materials
- (2016) Priscilla S. Briquez et al. Nature Reviews Materials
- Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis
- (2016) Kerri-Ann Norton et al. Scientific Reports
- Systems biology of the microvasculature
- (2015) Lindsay E. Clegg et al. Integrative Biology
- Molecular mechanism matters: Benefits of mechanistic computational models for drug development
- (2015) Lindsay E. Clegg et al. PHARMACOLOGICAL RESEARCH
- Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors
- (2015) Francois Bordeleau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery
- (2015) Christian J. Buchholz et al. TRENDS IN BIOTECHNOLOGY
- Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model
- (2015) Lindsay Wendel Clegg et al. PLoS Computational Biology
- Antiangiogenic Actions of Vascular Endothelial Growth Factor-A 165 b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity
- (2014) Doan T.M. Ngo et al. CIRCULATION
- An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease
- (2014) Ryosuke Kikuchi et al. NATURE MEDICINE
- Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164
- (2014) V. Sacchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing
- (2014) M. M. Martino et al. SCIENCE
- Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning
- (2013) Prakash Vempati et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Therapeutic angiogenesis for revascularization in peripheral artery disease
- (2013) Anna Grochot-Przeczek et al. GENE
- Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease
- (2013) B. Hoier et al. JOURNAL OF APPLIED PHYSIOLOGY
- Therapeutic angiogenesis for critical limb ischaemia
- (2013) Brian H. Annex Nature Reviews Cardiology
- Detection of VEGF-Axxxb Isoforms in Human Tissues
- (2013) David O. Bates et al. PLoS One
- Signal Transduction by Vascular Endothelial Growth Factor Receptors
- (2013) S. Koch et al. Cold Spring Harbor Perspectives in Medicine
- New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation
- (2012) Romain Delcombel et al. ANGIOGENESIS
- Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training
- (2012) W Schuyler Jones et al. VASCULAR MEDICINE
- Signal transduction by vascular endothelial growth factor receptors
- (2011) Sina Koch et al. BIOCHEMICAL JOURNAL
- The effect of vascular endothelial growth factor (VEGF) presentation within fibrin matrices on endothelial cell branching
- (2011) Sean M. Anderson et al. BIOMATERIALS
- Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
- (2011) K. Ballmer-Hofer et al. BLOOD
- Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing
- (2011) M. M. Martino et al. Science Translational Medicine
- VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model
- (2010) Florence T. H. Wu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
- (2010) M. O. Stefanini et al. CANCER RESEARCH
- A compartment model of VEGF distribution in blood, healthy and diseased tissues
- (2008) Marianne O Stefanini et al. BMC Systems Biology
- VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
- (2008) A H R Varey et al. BRITISH JOURNAL OF CANCER
- Vascular Endothelial Growth Factor (VEGF)-A165b Is a Weak In vitro Agonist for VEGF Receptor-2 Due to Lack of Coreceptor Binding and Deficient Regulation of Kinase Activity
- (2008) H. Kawamura et al. CANCER RESEARCH
- Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
- (2008) D. G. Nowak et al. JOURNAL OF CELL SCIENCE
- Systems Biology of Vascular Endothelial Growth Factors
- (2008) Feilim Mac Gabhann et al. MICROCIRCULATION
- Turning the gene tap off; implications of regulating gene expression for cancer therapeutics
- (2008) J. F. Curtin et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search